Global registrational trial to enroll approximately 160 adults with HP to support once-weekly canvuparatide’s potential as a best-in-class PTH replacement therapy CARMEL, Ind., and BURLINGTON, Mass., ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results